Previous close | 4.8500 |
Open | 4.8500 |
Bid | 5.5000 |
Ask | 5.7000 |
Strike | 90.00 |
Expiry date | 2025-01-17 |
Day's range | 4.8500 - 4.9000 |
Contract range | N/A |
Volume | |
Open interest | 1.04k |
Abbott Laboratories (NYSE: ABT) is seen as a solid safe-harbor stock because of the company's 135-year history, its diversified healthcare business, and its reliable dividend. Abbott is a global company with a huge reach in products and geography. Its segments are diagnostic products, medical devices, nutritional products, and established pharmaceutical products (branded generic medicines).
Abbott (ABT) closed at $98.93 in the latest trading session, marking a -1.35% move from the prior day.
Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.